Last reviewed · How we verify
Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis
The objective of this clinical study is to evaluate the safety and effectiveness of NB1 Bone Graft in subjects with degenerative disc disease undergoing transforaminal lumbar interbody fusion. It is estimated that up to 30 participants will be enrolled in approximately 3 clinical sites. During baseline and follow-up assessments, patients will be asked to undergo x-rays and CT scans; adverse events and immunology will be collected, and; participants will be requested to complete participant questionnaires regarding quality of life, pain and function.
Details
| Lead sponsor | Bone Biologics Corp |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 30 |
| Start date | Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Degenerative Disc Disease
- Spondylolisthesis
Interventions
- NB1
Countries
Australia